Sbarro Health Research Organization conducts research in cancer, diabetes, and cardiovascular disease. Based in Philadelphia, Pennsylvania on the campus of Temple University, our programs train young scientists from around the globe.


Temple Researcher's Work Spotlights Cancer Threat in Italy

June 13, 2014

Growing up in Naples, Italy, Antonio Giordano, founder of Sbarro Health Research Organization and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, College of Scence and Tecnology, Temple University was aware of the health hazards that resulted from unregulated industries and decades of illegal toxic-waste dumping in Italy's Campania region, the fertile agricultural areas that surround Naples.

In the 1970s, his father, Giovan Giacomo Giordano - an oncologist and a pathologist - published Health and Environment in Campania, the first white paper detailing the link between unregulated industries such as chemicals, paint, steel and asbestos in the regions around Naples and an increase in tumors among the population.

For more on this story, please see this article on the Temple News site.

Toxic Waste in Souhern Italy

April 29, 2014

The article "A toxic legacy" appeared in the scientific journal Nature regarding the drama of the biocide in Campania, left amazed and perplexed Italian scientists, experts and journalists.

For more information please see this Article .

Alzheimer's disease progression and its physiological aging: a new therapeutic scenario?

March 20, 2014

Toxidative stress, an imbalance of pro-oxidants and antioxidants, is linked to aging and many neurological disorders such as Alzheimer's disease, the most common form of dementia. In the recent years, a number of scientific publications have reported that PPARs, a group of nuclear receptor proteins controlling gene activity within our body, play an important role at normal and pathological levels in different tissues, including the nervous tissue. In fact, their involvement in neurodegenerative diseases, such as multiple sclerosis, amyotrophic lateral sclerosis, Alzheimer's, Parkinson's and Huntington's diseases, is well recognized. More, 4-HNE, a substance that initiates a physiological response when combined with one type of PPARs molecules, namely PPARβ/δ, is known to be involved in neurodegenerative diseases as well. Now, a new study from the Sbarro Health Research Organization and the University of L'Aquila (Italy) has investigated the role of 4-HNE and PPAR β/δ during AD progression and in physiological aging. The data obtained using a special AD animal model, indicate a novel destructive age-dependent role of PPARβ/δ in AD. This finding just published on Cell Cycle, may have important implications for the prevention of cognitive impairment in elderly and in neurodegenerative diseases. "Our studies point towards the possibility to use a specific PPARβ/δ antagonist for counteracting the disease progression" says Annamaria Cimini of the University of L'Aquila, lead author of the study. "Understanding the mechanism of action of physiological and pathological aging may provide a means to limit cognitive impairment progression" says Antonio Giordano, founder and President of the Sbarro Health Research Organization.

Panel Discussion: A "New" Southern Question: Citizens of a Poisoned Paradise

March 18, 2014

The Italian Language Inter-Cultural Alliance will host free Panel Disussion with authors Pino Aprile & Antonio Giordano on April 4th, 2014 at The John D. Calandra Italian American Institute in New York.

For more information please see this Announcement .

Searching for the Magic Bullet Against Cancer Caused by Asbestos: One Step Closer?

January 19, 2014

Mesothelioma is a very aggressive cancer associated with asbestos exposure, which is usually diagnosed in an advanced stage with poor prognosis. In December, the research team of Antonio Giordano published two separate studies aiming to address the urgent need to identify possible new methods for mesothelioma treatment.

For more information please see this NewsWise Release

Tumor-suppressing genes could play important role in obesity, diabetes and cancer

December 13, 2013

The function of two tumor-suppressing genes could play a vital role in helping to control obesity and other diseases such as diabetes, heart disease and cancer, according to researchers in Temple University's Sbarro Institute for Cancer Research and Molecular Medicine.
The researchers published their findings, "Silencing of RB1 and RB2/p130 during adipogenesis of bone marrow stromal cells results in dysregulated differentiation," in the Feb. 1, 2014, issue (online Nov. 25) of the journal Cell Cycle.

For more information please see this Eureka Release and NewsWise Release

An upcoming workshop to explore the endless potential of tissue microarrays

November 17, 2013

The Sbarro Health Research Organization, the College of Science and Technology of Temple University, Integrated Systems Engineering (ISENET) and ISENET-USA LLC teamed up to organize a Tissue Microarray (TMA) Workshop on the value of the TMA technology in biomarker validation, drug response and diagnostics on November 20th, 2013, at University City Science Center, 3711 Market Street, Philadelphia PA.

For more information please see this Release and Agenda

Cancer Mortality in the Metropolitan Area of Naples and Caserta Between 1988 and 2009: Lights and Shadows on Southern Italy

October 19, 2013

A new study on cancer mortality in the metropolitan area of Naples and Caserta, Southern Italy, has been published in the scientific journal Cancer Biology & Therapy. The authors belong to a multidisciplinary Italian-American team including researchers from the G. Pascale Foundation (Naples, Southern Italy), Regina Elena National Cancer Institute (Rome, Central Italy) and the Sbarro Institute for Cancer Research of Philadelphia, USA.

For more information please see this NewsWise Release .

Conference on "Current Advances in Medicine, Surgery and Biotechnology"

October 10, 2013

A confernce sponsored by SHRO and the National Italian American Foundation will be held in Washington DC on October 26, 2013. For more details see attached announcement

Can the zebrafish help us to search for new pain drugs?

August 16, 2013

Neuropathic pain is caused by injury of the central or peripheral nervous system. Neuropathic pain is difficult to treat because rarely responds to opiates. Studying neuropathic pain in humans has major ethical and experimental limitations. The use of alternate mammalian animal models has been the solution for many years. For both human and animal studies scientists had to rely frequently on behavioral tests that may not directly reflect the experience the animal is going through. Thus, this may be one of the reasons because our ability to treat pain symptoms still relies on a small number of drugs. This suggests that the use of other model systems may help to discovery new compounds with potential analgesic activity.

A new published study in Journal of Cellular Physiology by a team led by Dr. Antonio Giordano and Dr. Gianfranco Bellipanni of Sbarro Institute for Cancer Research and Molecular Medicine and Temple University (Philadelphia, USA) adds a new prospective on the research on pain perception. They used larvae of the small vertebrate zebrafish to show that at the molecular level they respond to stimuli that induce inflammation and axons degenerations similarly to mammals.

"We found the highest temperature zebrafish larvae could survive and exposed them for only 5 seconds, the results where similar to human severe skin burns. " Dr. Giordano said. "Then we went to see if the panel of genes, activated by pain in humans, was activated also in the fish. Interestingly, they were activated at the right place and time". We asked Dr. Gianfranco Bellipanni to explain how this research could have implications for humans: "to understand better the mechanism of neuropathic pain and to discovery new drugs first we need an animal model that is easy and economic to keep, that shows a high degree of similarity in pain perception and response with mammals and is especially able to offer many technical tools for conducting studies. Zebrafish matches all these characteristics" he said. "Now we are creating transgenic zebrafish that became fluorescent in response to painful stimulations. These transgenic fish can be used for in vivo studies. At first we will use these transgenic fish to characterize better the cellular and molecular mechanisms of pain, but our final goal, if we will find the appropriate funding, is to use them for screening for chemicals with potential analgesic activity".

Other authors of the study include Dr. Valentina Malafoglia and William Raffaeli both at ISAL-Foundation, Institute for Research on Pain, Dr. Marco Colasanti at University of Roma 3 and Dr. Darius Balciunas at Temple University.

Dr. Antonio Giordano is Director and Founder of Sbarro Health Research Organization at Philadelphia, PA ( and Professor of Pathology and Oncology at University of Siena, Italy.

For more information please see this NewsWise Release .

Vitamin D and Breast Cancer Prevention: what's the current evidence from randomized clinical trials?

July 31, 2013

Rome, Central Italy
The study entitled "Vitamin D Supplementation and Breast Cancer Prevention: A Systematic Review and Meta-analysis of Randomized Clinical Trials" has been recently judged suitable for publication in PLOS ONE and will be available at from 5pm ET on July 22nd 2013.

The authors belong to a multidisciplinary, international team led by Dr. Maddalena Barba, researcher at the Regina Elena National Cancer Institute of Rome, Central Italy.

"In recent years, the scientific evidence linking vitamin D to breast cancer has grown notably. Several systematic reviews including randomized clinical trials have recently focused on vitamin D and health outcomes. However, so far, no systematic review has specifically addressed the role of vitamin D supplementation in breast cancer prevention" says Prof. Antonio Giordano, an internationally renowned oncologist engaged for years in the fight against breast cancer.

"The conduct of a systematic review allows to collate all evidence that fits pre-specified eligibility criteria on a specific research question. It is always desirable to review a body of data systematically in that such an assessment holds the potentials to orient future steps and health priorities in a specific research setting. This approach is particularly appropriate when dealing with issues with broad reflections in terms of public health, such as breast cancer related outcomes" adds Prof. Giordano.

In this study, the researchers focused on breast cancer, the most commonly diagnosed cancer and the second leading cause of cancer death in women from Western countries. "This systematic review was carried out in full agreement with the methods applied by the Cochrane collaboration, an international not-for-profit organization preparing, maintaining and promoting the accessibility of systematic reviews of the effects of health care and prevention worldwide. Our work contributes a comprehensive appraisal of the evidence stemming from randomized controlled trials on vitamin D supplementation for breast cancer prevention. Based on our results and considering the intrinsic limitations of the scientific evidence examined, vitamin D supplementation seems not to be associated with a reduced risk of breast cancer development in women. However, the scientific panorama related to the association of interest is still limited and overall inadequate to draw firm conclusions" clarifies Dr Barba.

"New trials specifically tailored on the vitamin D-cancer- binomious are in progress and should provide additional information in a few years' time. Methodological tools and key tenets of vitamin D metabolism and biological activities will help interpret the upcoming results" concludes Prof. Giordano.

For more information please see this NewsWise Release .

Virtual Reality and Weight Loss

July 1st, 2013

Can virtual reality help losing weight?
Can an avatar in a virtual environment contribute to weight loss in the real world?

"Virtual reality is a powerful computer simulation of real situations in which the user interact as avatar and it can be used as support for a weight loss program" said Dr. Antonio Giordano and Dr. Giuseppe Russo of Sbarro Institute for Cancer Research and Molecular Medicine (Philadelphia, PA), in a study just published in Journal of Diabetes Science and Technology.

Over 60% of all Americans are overweight or obese and it is very difficult to keep the weight off. Diets and/or miracle pills and exercise programs? NO, the battle is still on.

"In this pilot study, we have created different virtual scenes where an avatar has to live everyday tasks such as walking on a treadmill or healthy grocery shopping" said Dr. Giordano and Dr. Russo. The international team created a DVD showing an overweight avatar living different virtual daily situations. The team enrolled 8 overweight American women and demonstrated that this DVD helped these participants to gather new information on how to lose weight. "This study represents how virtual reality can contribute to behavioral improvement of human health" concluded Dr. Giordano and Dr. Russo.

Other authors of the study include Dr. Melissa Napolitano at George Washington University, Dr. Sharon Hayes and Dr. Gary Foster both at Temple University and Dr. Debora Muresu at Sbarro Institute for Cancer Research and Molecular Medicine.

Dr. Antonio Giordano is Director and Founder of Sbarro Health Research Organization at Philadelphia, PA ( and professor of Pathology and Oncology at University of Siena, Italy.

For more information please see this SHRO Diary Page or this SHRO Website Release .

Novel findings in gastric cancer research at the 10th IGCC (International Gastric Cancer Congress)

June 27th, 2013

The 10th IGCC, placed in Verona from 19th to 22nd of June, was focused on the various features related to causes, development and management of the gastric cancer, which represent one of the most frequent cause of cancer death. The topics considered both clinical, and diagnostic, and biomolecular viewpoints, a llowing to have an overview of the stomach tumor. The event was sponsored also by IGCA (International Gastric Cancer Association) and by GIRGC (from the Italian acronym Gruppo Italiano Ricerca sul Cancro Gastrico). Among the prominent names of invited speakers and chairmen, there were professor Franco Roviello, from the University of Siena, professor Parry Guilford, from the Otago University (New Zealand), professors Carneiro and Seruca, from the Porto University (Portugal) and professor Antonio Giordano, from the Temple University (United States).

For more information please see this DoctorMag Release .

Dr. Klein appointed dean of Temple's College of Science and Technology

June 18th, 2013

Congratulations to Dr. Michael L. Klein on his appointment as the dean of the College of Science and Technology (CST) at Temple. It is a pleasure knowing that his dedication and skills are of a great value and recognition of this kind is well deserved.

For more information please see this Temple News Release .

Rome Calls For Doctor's Care

June 17th, 2013

The Sbarro Health Research Organization congratulates Senator Ignazio R. Marino on his recent winning of the mayoral race for the Italian Capital, Rome. Before embarking on his political career, Dr Marino worked as a Professor of Surgery, first in Pittsburgh and then in Philadelphia, where he chaired the Division of Transplantation of the Thomas Jefferson University Hospital.

For more information please see this Newswise Release or this pdf file .

Campania Teams Up Against Breast Cancer

June 5th, 2013

International symposium held on many aspects of breast cancer on May 29th and 30th. It was held in the beautiful framework of Badia, Cava de 'Tirreni, at The Hotel Scapolatiello, the VII National Conference of ASME (Mediterranean Association of Senology - entitled "Breast cancer: state of the art".

For more information please see this Newswise Release .

In Memoriam of Dr. George W. Katter

In Memoriam of Dr. George W. Katter

April 20, 1919 - May 24, 2013

The Sbarro Health Research Organization (SHRO) and the Temple University community would like to extend their condolences to the family of Dr. George W. Katter of Johnstown, PA, who passed away on May 24, 2013 at the age of 94.

A graduate of the University of Notre Dame and Georgetown University Medical School, Dr. Katter began his medical career in Washington, D.C. While serving as adjunct professor of medicine at Georgetown, he cofounded the Center for Cardiovascular Research, collaborating with leading figures in American cardiology. Dr. Katter was part of the Georgetown team that designed and prototyped the first cardiac catheterization procedure. Additionally, he founded the Mother McCauley Medical Clinic at Mercy Hospital, where thousands of uninsured patients are treated today.

Upon his retirement in 1998, Dr, Katter founded and later became president emeritus of the Johnstown Free Medical Clinic. For years he traveled to Haiti to train physicians and health care professionals, as well as to care for impoverished patients.

In recognition of his lifetime of work, Dr. Katter was inducted into the knighthood of the Sovereign Order of Malta by Cardinal John O'Connor and remained an active member until his passing.

In October of 2011, at the National Italian American Foundation's 36th anniversary awards convention in Washington, D.C., Dr. Katter was named the recipient of the second annual Giovan Giacomo Giordano Foundation and the National Italian American Foundation Award for Ethics and Creativity in Medical Research. Upon presenting the award, Dr. Antonio Giordano, President of SHRO and Director of the Center for Biotechnology at Temple University in Philadelphia, said "Dr. George Katter exemplifies the ideals of this award with his admirable, charitable and ethical approach to practicing and distributing medical care to the impoverished."

In addition to his important work in cardiovascular research, Dr. Katter was instrumental in facilitating significant endowments to the University of Notre Dame and Georgetown University focused on advancing science education, as well as to the Sbarro Health Research Organization at Temple University, supporting biomedical research in the Italian-American scientific community, through SHRO's internationally recognized breast cancer research program.

Plea for Correct Stem Cell Research in Europe

May 25th, 2013

The "Stem Cell Research Italy" Association ( and the "Sbarro Health Research Organization" ( make a public plea for a correct use of stem cell therapy in Italy and Europe.
Stem Cell Research Italy (SCR Italy) strongly endorses the point of view of eminent scientists who published a commentary on the regulation of stem cell therapy in Europe (Bianco et al "Regulation of stem cell therapies under attack in Europe: for whom the bell tolls" EMBO J. 2013 May 3. doi: 10.1038/emboj.2013.114).

For more information please see this Newswise Release .

His Excellency Claudio Bisogniero, Italian Ambassador to the United States, will visit Temple's Sbarro Institute for Cancer Research and Molecular Medicine

May 16th, 2013

On Friday, May 17, 2013, at 10:30 AM, His Excellency Claudio Bisogniero, Italian Ambassador to the United States will visit Temple to honor the excellence in American-Italian research collaboration as exemplified by the Sbarro Institute at Temple. He will be joined in his tour by Temple President Neil Theobold, Provost Hai-Lung Dai, College of Science and Technology Dean Michael Klein and Sbarro Director Antonio Giordano.

For more information please see this Temple News Release For a summary if visit, please see this Temple News Release.

The Power of Cocoa Polyphenols Against Neurodegenerative Diseases

April 11th, 2013

Epidemiological studies have indicated that dietary habits and antioxidants from diet can influence the incidence of neurodegenerative disorders such as Alzheimer's and Parkinson's diseases. Now, a new study from the Sbarro Health Research Organization (SHRO), Center for Biotechnology, Temple University, Philadelphia PA and Lombardi Cancer Center , Georgetown University Washington DC (USA) , University of University of L'Aquila (Italy) and University of Siena (Italy) shows that cocoa polyphenols triggers neuroprotection by activating BDNF survival pathway, both on Aβ plaque treated cells and on Aβ oligomers treated cells, resulting in the counteraction of neurite dystrophy,

For more information please see this Newswise article .

Important International Study on the Link Between Obesity and Breast Cancer

April 3rd, 2013

The link between obesity and cancer seems now well established although the molecular mechanisms underlying this connection are still largely unexplored. A group of researchers in Italy led by Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, and Center of Biotechnology, College of Science and Technology of the Temple University in Philadelphia, has studied the correlation between breast cancer and insulin resistance - an obesity-related condition in which certain cells fail to respond to the glucose-lowering action of the insulin hormone.

Their findings appear in the Journal of Experimental and Clinical Cancer Research.

For more information please see this Newswise article .

Pfizer CDK Inhibitor and Cancer Progression

March 16th, 2013

Data from a recent clinical study by Pfiezer has renewed interest in CDK inhibitors to block the progress of Cancer. The concept was featured in a Nature Biotechnology article. "The main issue is to understand which CDKs should be targeted in specific cancers where they have a key role in the oncogenic process" stated Dr. Antonio Giordano of the Sbarro Institute for Cancer Research and Molecular Medicine, Temple University in Philadelphia. Dr. Giordano was the first to discover CDK9 and to describe a link between cyclins/CDKs and tumorigenesis.

For more information please see this article .

Increased Incidence of Breast Cancer in Italy

November 30th, 2012

A new study on the incidence of breast cancer in Italy has been published in the International Journal of Experimental and Clinical Cancer Research. The authors belong to a multidisciplinary Italian-American team led by Prof. Antonio Giordano, Director of the Sbarro Institute for Cancer Research and Molecular Medicine College of Science and Technology Temple University of Philadelphia, USA.

"Cancer is also a matter of numbers," says Giordano, internationally renowned oncologist engaged for years in the fight against cancer, who recently launched an appeal - signed by over 500 researchers - to protect the environment from the irresponsible dumping of toxic wastes, carcinogenic waste. "The identification of the precise number of cancer cases at a population level and by geographical area is crucial to orient public health strategies towards cancer prevention and early diagnosis."

SHRO Press Release
For more information please see the interview with Dr. Giordano and this article .

Dr. Giordano receives International Award

November 13th, 2012

Antonio Giordano, M.D., Ph.D. is being awarded the Grande Ippocrate Award for Scientific Research and Communication. The award ceremony will take place at the "Castel Nuovo"on November 19, 2012.
More Details       Conference Program      

Conference on Breast Cancer: Bridging Research and Clinical Medicine

October 6th, 2012

On October 12, 2012, from 2:00 to 4:00 p.m., the Sbarro Health Research Organization, Inc. (S.H.R.O.), the Giovan Giacomo Giordano Foundation, the College of Science and Technology at Temple University and the National Italian American Foundation (NIAF) ( will jointly present the "Conference on Breast Cancer: Bridging Research and Clinical Medicine" on the occasion of NIAF's 37th anniversary gala weekend at the Hilton Hotel in Washington, D.C.
SHRO Press Release       Conference Details      

Toxic Dumping in Naples Leads to Increased Cancer Rates in Naples

August 21st, 2012

On July the 30th, the Pascale National Cancer Institute of Naples made a shocking report: 47% more people are stricken with cancer in Naples than in the rest of the Italy.
SHRO Press Release

New Properties of Stem Cells via Simulated Microgravity

July 5th, 2012

A recent study led by Andrew Puca, Ph.D. under the supervision and direction of Antonio Giordano, M.D., Ph.D. set out to illustrate novel mechanical transduction properties of Hematopoietic Stem Cells in relation to defining the expression of humoral factors by facilitating paracrine/autocrine signalling via microgravity.
PubMed   Rest of NewsWise Press Release

S.H.R.O. hosts free seminar on commercialization of science.

June 1, 2012

S.H.R.O., in collaboration with Temple University's College of Science & Technology, the Italian Trade Commission and Innova Consulting Group, will host a seminar that aims to provide concrete tools and examples to support the commercialization of science research by creating start-ups.
Flyer   Invitation

"The Price of a False Idea about Economic Growth: Health Research Cuts and Uncontrolled Toxic Agents"

May 9, 2012

In this new essay, Philosopher Sheldon W. Samuels takes us to the heart of the budget and regulatory battles that engulf the courts, congress and administration to explain the long history resulting in the sidelining of disease prevention and obstruction in controlling environmental threats to human life.

Novel Mechanism May Lead to New Targeted Pharmacological Cancer Treatment

April 24, 2012

In a new study from the Sbarro Health Research Organization, Flavio Rizzolio shows that Pin1 (protein interacting with NIMA (never in mitosis A)-1), a peptidylprolyl isomerase involved in the control of protein phosphorylation, is an essential mediator for inactivation of the pRB. The findings, published in Cell Death and Differentiation, have important implications for cancer treatment.
Temple News Release   Abstract in PubMed

Eight Rules For Living better

March 28, 2012

This article, published in Italian in the online journal La Gazzetta Gastronomica, outlines eight simple rules that the World Cancer Research Fund recommends for achieving a healthy lifestyle.

Italy's Eco Mafia. Mafia Are Cashing In On Toxic Dumping and Other Environmental Crimes.

March 28, 2012

Christine MacDonald's article published in E Magazine (March/April 2012) discusses how the Mafia has continued to commit atrocious environmental crimes (more than 30,000 in 2010 in Italy alone, according to the Italian environmental group Legambiente). These include trafficking in exotic animals and stolen timber, running illegal slaughterhouses and schemes to redirect water resources. An investigation led by the Sbarro Health Research Organization's President, Antonio Giordano, MD, PhD, found higher rates of cancers, cancer deaths and serious birth defects in areas where dumping had occurred. The findings were published in the journal Cancer Biology & Therapy last July. "There is no doubt," Giordano says, "that the waste dumped on farmland in the region going back at least to the 1970s is responsible for the higher tumor rates, birth defects and other health problems in a region long known for its fertile pastures and healthy people."

The Mystery of the 2012 Flu Season: Where are the Sick People?

January 26, 2012

An article in the Daily Beast asks: If this is flu season, why is no one getting sick? The commentary notes that while people should be "hacking and sneezing and aching" the Center for Disease Control and Prevention reports that the flu is at "relatively low" levels as of January 2012.

Scriptaid Effects on Cancer Cell Lines

January 16, 2012

Although endocrine therapy for breast cancer has shown excellent results in controlling
the disease, responsiveness to the therapy depends on whether or not there is expression of estrogen receptors in breast cancer cells. Research from the Sbarro Institute for Cancer Research and Molecular Medicine reports on the effectiveness of a new molecule, Scriptaid, that restores receptivity to endocrine therapy in breast cancer cell lines that had tested negative for the expression of estrogen receptors. The findings are reported in the Journal of Cellular Physiology.

Grant Helps Build NeuroAIDS  Research Capacity at Temple University School of Medicine

January 11, 2012

The National Institute of Mental Health (NIMH) has awarded Temple University a five-year, $8.34 million grant to create a Comprehensive NeuroAIDS Core Center (CNAC) at the School of Medicine.

The new center, one of only nine funded by NIMH, will enable researchers to study basic science and clinical aspects of HIV-induced neurological diseases and neurocognitive disorders. Kamel Khalili, Laura H. Carnell Professor and chair of neuroscience, is the principal investigator on the project.


Study Links Birth Defects in Fallujah to U.S. Assaults

January 4, 2012

A dramatic spike in birth defects in the Iraqi city of Fallujah may be caused by genetic damage  from weaponry used in American assaults that took place six years ago, according to a study published in the International Journal of Environmental Research and Public Health.

Novel Evidence Links Pretreatment Fasting Glucose to Slowed Cancer Progression

December 6, 2011

Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine and the Human Health Foundation report that in a multidisciplinary study of 420 non-diabetic, breast and metastatic colorectal cancer patients treated with targeted agents, lower levels of pretreatment fasting glucose were predictive of longer times to disease progression.

Such evidence was particularly significant in breast cancer patients, according to results published in the Annals of Oncology.

Medicare To Cover Obesity Prevention Services

December 2, 2011

Obese patients will now be eligible for fully paid screening and weight loss counseling sessions under Medicare, the Centers for Medicare and Medicaid Services announced.

"I believe this is a great development that should set policy basis for other insurance providers. Innovative counseling programs will likely enhance still insufficient awareness about obesity and its serious health consequences," said Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University’s College of Science and Technology.






All funds raised go to genetic research to help cure and diagnose cancer, cardiovascular disease, diabetes, and HIV-AIDS.

NEW! Redeem Your Credit Card Points to Support SHRO at CharityChoice


> Redeem your credit card points and employee rewards
> Give like a regular commercial gift card.
> Turn your gift-giving into philanthropy
> 100% tax deductible, plastic and ecards

CharityChoice Gift Cards
Cards Benefit Sbarro Health Research Organization.
Perfect for birthday, business, holiday, sympathy, wedding - a unique gift idea


GoodSearch cause banner Buy at Amazon - Support SHRO Buy Green and Support SHRO Support Human Health Foundation

Become a SHRO Fan on Facebook   Don't miss any SHRO tweets!!


Using Office Outlook Web Access Secure Login


TOP   |    CONTACT   |    SALUTE-PRESS   |    DONATE   |    LINKS

© Copyright 2003 - 2010, Sbarro Health Research Organization,All rights reserved.